Skip to content
PeptideAgent

Telehealth providers in Nebraska

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

Telehealth prescribing is allowed in Nebraska. What Nebraska requires of telehealth prescribers and pharmacies, plus verified listings.

Nebraska at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified telehealth providers serving Nebraska

No verified telehealth providers serving Nebraska are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Telehealth prescribing rules in Nebraska

Neb. Rev. Stat. section 38-1,143, in the Uniform Credentialing Act, provides that a credential holder who is providing a telehealth service to a patient may prescribe the patient a drug if the credential holder is authorized to prescribe under state and federal law, and lets the Department adopt consistent rules. The Nebraska Telehealth Act (Neb. Rev. Stat. sections 71-8501 to 71-8508) sets telehealth consent and coverage rules, mainly for Medicaid. The prescriber must hold a Nebraska credential. Neither statute expressly addresses questionnaire-only asynchronous prescribing, so this record leaves it unconfirmed; the standard of care still applies. None of the peptides in this database are controlled substances. [2] [3]

Compounded GLP-1 access in Nebraska

Nebraska patients using telehealth GLP-1 programs should confirm that the shipping pharmacy holds a Nebraska mail service pharmacy license in the DHHS license lookup. [7] [9]

Research use only sellers in Nebraska

The Nebraska Pharmacy Practice Act limits dispensing of prescription drugs to licensed pharmacies and practitioners, so sellers of "research use only" injectable peptides to Nebraska consumers are not lawful dispensers in the state. [4] [10]

How to check a telehealth provider in Nebraska

  1. Confirm the prescriber is licensed or registered to treat patients located in Nebraska; the telehealth rules above explain what Nebraska requires. [2] [3]
  2. Ask which pharmacy will fill the prescription and check it in the Nebraska Board of Pharmacy (licensing through the Department of Health and Human Services, Division of Public Health, Licensure Unit) license lookup. [1] [4] [5] [6] [7] [8]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Nebraska. [4] [10]

Common questions in Nebraska

Can I get a GLP-1 prescription in Nebraska through telehealth?

Yes. Neb. Rev. Stat. section 38-1,143 lets a Nebraska credential holder who is providing telehealth prescribe any drug they are authorized to prescribe, and semaglutide and tirzepatide are not controlled substances. [2]

Can an out-of-state pharmacy ship compounded peptides to me in Nebraska?

Only if it holds a Nebraska mail service pharmacy license from DHHS. If the pharmacy does not appear in the Nebraska license lookup, the shipment is not lawful in Nebraska. [5] [7]

All peptide legal questions for Nebraska

Sources

  1. [1]Nebraska DHHS Licensure Unit: pharmacist and Board of Pharmacy information
  2. [2]Neb. Rev. Stat. section 38-1,143, Telehealth; prescribing
  3. [3]Nebraska Telehealth Act, Neb. Rev. Stat. sections 71-8501 to 71-8508 (DHHS compilation)
  4. [4]Nebraska statutes relating to the Pharmacy Practice Act (DHHS compilation)
  5. [5]Neb. Rev. Stat. section 71-2407, Mail service pharmacy license; requirements; fee
  6. [6]Neb. Rev. Stat. section 38-2867.01, Authority to compound; standards; labeling; prohibited acts
  7. [7]Nebraska DHHS: mail service pharmacy initial license application
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  10. [10]21 U.S.C. 331, Prohibited acts